Fasiglifam, TAK-875
Lintlha tsa Sehlahisoa
Li-tag tsa Sehlahisoa
| Boholo ba Pakete | Ho fumaneha | Theko (USD) |
Lebitso la lik'hemik'hale:
(S) -2-(6-((2',6'-dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy) -2,3 -dihydrobenzofuran-3-yl)acetic acid
SMILES Khouto:
O=C(O)C[C@@H]1COC2=CC(OCC3=CC(C4=C(C)C=C(OCCCS(=O)(C)=O)C=C4C)=CC=C3 )=CC=C12
Khoutu ea InChi:
InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21( 14-22)17-35-24-8-9-2 6-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2, 1-3H3,(H,30,31)/t23-/m1/s1
InChi Key:
BZCALJIHZVNMGJ-HSZRJFAPSA-N
Keyword:
1000413-72-8;CAS:1000413-72-8;CAS:1000413-72-8;TAK875;TAK-875;TAK 875;Fasiglifam
Sollubility:E qhibiliha ka DMSO, eseng ka metsing
Polokelo:0 - 4 C bakeng sa nako e khutšoanyane (matsatsi ho isa ho libeke), kapa -20 C bakeng sa nako e telele (likhoeli).
Tlhaloso:
Fasiglifam (TAK-875) ke agonist e sebetsang, ea molomo, le e khethang ea GPR40.
Sepheo: GPR40 agonist
